Terms: = Myeloproliferative Neoplasm AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
29 results:
1. siRNA-mediated downregulation of BATF3 diminished proliferation and induced apoptosis through downregulating c-Myc expression in chronic myelogenous leukemia cells.
Dabbaghipour R; Khaze Shahgoli V; Safaei S; Amini M; Tabei S; Shanehbandi D; Rahbar Farzam O; Baradaran B; Entezam M
Mol Biol Rep; 2024 Jan; 51(1):100. PubMed ID: 38217769
[TBL] [Abstract] [Full Text] [Related]
2. [Development of novel therapeutic agents for myelofibrosis].
Yamaguchi H
Rinsho Ketsueki; 2023; 64(10):1298-1305. PubMed ID: 37914245
[TBL] [Abstract] [Full Text] [Related]
3. [Chemotherapy Combined with Venetoclax Followed by Allo-Hematopoietic Stem Cell Transplantation for Treatment of Blastic Plasmacytoid Dendritic Cell neoplasm].
Cheng P; Wang LL; Wang QX; Guan J; Zhou Y; Hu B; Feng Y; Zou L; Cheng H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1531-1536. PubMed ID: 37846712
[TBL] [Abstract] [Full Text] [Related]
4. Validation of a New Prognostic Score in Patients with Ovarian Adenocarcinoma.
Trifanescu OG; Mitrica RI; Gales LN; Marinescu SA; Motas N; Trifanescu RA; Rebegea L; Gherghe M; Georgescu DE; Serbanescu GL; Bashar HH; Dragosloveanu S; Cristian DA; Anghel RM
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837431
[No Abstract] [Full Text] [Related]
5. [Clinical Characteristics and Treatment of Blastic Plasmacytoid Dendritic Cell neoplasm].
Zhang XL; Liu B; Li N; Li LK; Ji XJ; Zhou XF; Wang MF; Xu HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):254-260. PubMed ID: 36765508
[TBL] [Abstract] [Full Text] [Related]
6. ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasms.
Mannelli F; Guglielmelli P; Fazi P; Crea E; Piciocchi A; Vignetti M; Amadori S; Pane F; Venditti A; Vannucchi AM
Future Oncol; 2023 Jan; 19(2):103-111. PubMed ID: 36651780
[TBL] [Abstract] [Full Text] [Related]
7. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics.
Adimora IJ; Wilson NR; Pemmaraju N
Cancer; 2022 Aug; 128(16):3019-3026. PubMed ID: 35726525
[TBL] [Abstract] [Full Text] [Related]
8. RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses.
Adnan Awad S; Dufva O; Ianevski A; Ghimire B; Koski J; Maliniemi P; Thomson D; Schreiber A; Heckman CA; Koskenvesa P; Korhonen M; Porkka K; Branford S; Aittokallio T; Kankainen M; Mustjoki S
Leukemia; 2021 Apr; 35(4):1087-1099. PubMed ID: 32782381
[TBL] [Abstract] [Full Text] [Related]
9. Blastic plasmacytoid dendritic cell neoplasm in the background of myeloproliferative disorder and chronic lymphocytic leukaemia.
Khan AM; Munir A; Raval M; Mehdi S
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31308179
[TBL] [Abstract] [Full Text] [Related]
10. Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia.
Scherr M; Kirchhoff H; Battmer K; Wohlan K; Lee CW; Ricke-Hoch M; Erschow S; Law E; Kloos A; Heuser M; Ganser A; Hilfiker-Kleiner D; Heidenreich O; Eder M
Leukemia; 2019 Jun; 33(6):1313-1323. PubMed ID: 30546081
[TBL] [Abstract] [Full Text] [Related]
11. Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph+ Acute Lymphoblastic Leukemia.
Minieri V; De Dominici M; Porazzi P; Mariani SA; Spinelli O; Rambaldi A; Peterson LF; Porcu P; Nevalainen MT; Calabretta B
Cancer Res; 2018 Oct; 78(20):5793-5807. PubMed ID: 30154155
[TBL] [Abstract] [Full Text] [Related]
12. A novel synthesized 3', 5'-diprenylated chalcone mediates the proliferation of human leukemia cells by regulating apoptosis and autophagy pathways.
Zhang YQ; Wen ZH; Wan K; Yuan D; Zeng X; Liang G; Zhu J; Xu B; Luo H
Biomed Pharmacother; 2018 Oct; 106():794-804. PubMed ID: 29990873
[TBL] [Abstract] [Full Text] [Related]
13. PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β.
Fan RF; Lu Y; Fang ZG; Guo XY; Chen YX; Xu YC; Lei YM; Liu KF; Lin DJ; Liu LL; Liu XF
Mol Med Rep; 2017 Oct; 16(4):4603-4612. PubMed ID: 28849186
[TBL] [Abstract] [Full Text] [Related]
14. Diagnosis and classification of hematologic malignancies on the basis of genetics.
Taylor J; Xiao W; Abdel-Wahab O
Blood; 2017 Jul; 130(4):410-423. PubMed ID: 28600336
[TBL] [Abstract] [Full Text] [Related]
15. High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia.
Lucas CM; Milani M; Butterworth M; Carmell N; Scott LJ; Clark RE; Cohen GM; Varadarajan S
Leukemia; 2016 Jun; 30(6):1273-81. PubMed ID: 26987906
[TBL] [Abstract] [Full Text] [Related]
16. Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia.
Zhu X; Zhao H; Lin Z; Zhang G
Cancer Gene Ther; 2015 Dec; 22(12):573-80. PubMed ID: 26494558
[TBL] [Abstract] [Full Text] [Related]
17. Mechanisms of resistance in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Perekhrestenko T; Diachenko M; Sviezhentseva I; Gordienko A; Bilko D
Georgian Med News; 2015 Mar; (240):43-50. PubMed ID: 25879558
[TBL] [Abstract] [Full Text] [Related]
18. Significance of thrombocytosis in clinicopathologic characteristics and prognosis of gastric cancer.
Li FX; Wei LJ; Zhang H; Li SX; Liu JT
Asian Pac J Cancer Prev; 2014; 15(16):6511-7. PubMed ID: 25169479
[TBL] [Abstract] [Full Text] [Related]
19. Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.
Wang J; Li Z; He Y; Pan F; Chen S; Rhodes S; Nguyen L; Yuan J; Jiang L; Yang X; Weeks O; Liu Z; Zhou J; Ni H; Cai CL; Xu M; Yang FC
Blood; 2014 Jan; 123(4):541-53. PubMed ID: 24255920
[TBL] [Abstract] [Full Text] [Related]
20. Reverse phase protein array profiling reveals distinct proteomic signatures associated with chronic myeloid leukemia progression and with chronic phase in the CD34-positive compartment.
Quintás-Cardama A; Qiu YH; Post SM; Zhang Y; Creighton CJ; Cortes J; Kornblau SM
Cancer; 2012 Nov; 118(21):5283-92. PubMed ID: 22517119
[TBL] [Abstract] [Full Text] [Related]
[Next]
